CRVO,CervoMed Inc. | Healthcare - www.financetom.com

Healthcare

CRVO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

CervoMed Inc.CRVO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.

It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery.

The company is based in Boston, Massachusetts.

Latest News >

Best financial ETFs: Top funds for banks, insurers and REITs

Apr 5, 2024

Portions of this article were drafted using an in-house natural language generation platform. The article was reviewed, fact-checked and edited by our editorial staff. If you're wondering how to invest in the financial sector, exchange-traded funds (ETFs) can be a simple way to get started. ETFs that focus on the financial sector invest in companies that are involved in different...

Best energy ETFs: Top oil, gas and clean energy funds

Apr 5, 2024

If you're looking to invest in the energy sector, which historically has included mostly oil and gas companies, buying an energy exchange-traded fund (ETF) is an easy way to do that. With an energy ETF you can buy a cross-section of the industry, letting you play the sector if you think it's about to rally. An ETF also offers diversification,...

BofA urged by proxy advisers to split CEO, chair roles

Apr 5, 2024

April 5 (Reuters) - Proxy advisers Glass Lewis and Institutional Shareholder Services (ISS) on Friday both urged Bank of America ( BAC ) to split the CEO and chairman roles held by Brian Moynihan. Appointment of a chair of the board who is independent of management, i.e. not also serving as CEO, is nearly always preferable to having a single...

BofA urged by proxy advisers to split CEO, chair roles

Apr 5, 2024

(Reuters) - Proxy advisers Glass Lewis and Institutional Shareholder Services (ISS) on Friday both urged Bank of America ( BAC ) to split the CEO and chairman roles held by Brian Moynihan. Appointment of a chair of the board who is independent of management, i.e. not also serving as CEO, is nearly always preferable to having a single individual lead...